Journal
CLINICAL RESEARCH IN CARDIOLOGY
Volume 106, Issue 7, Pages 475-484Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00392-017-1095-0
Keywords
Hypertension; Resistant hypertension; Glucose intolerance; Angiotensin receptor neprilysin inhibitor; Renal denervation; SPRINT
Categories
Ask authors/readers for more resources
Hypertension is the most common chronic cardiovascular condition with increasing prevalence all over the world. Treatment of patients at risk requires a multimodal therapeutic concept to adjust blood pressure, including systematic identification of secondary causes of hypertension or pseudo-resistance, lifestyle modification, polypharmacy, and as well as accompanying risk factors and comorbidities. The present review discusses recent studies on patients with increased cardiovascular risk potentially influencing future treatment strategies. It covers blood pressure targets in patients at risk (SPRINT), novel treatment options such as angiotensin receptor neprilysin inhibitors, discusses the treatment of patients with impaired glucose tolerance, and appreciates novelties in controlling therapy-resistant hypertension by fourth-line pharmacotherapies (PATHWAY), as well as new interventional approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available